Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development

<b>Background/Objectives:</b> pentane polyene antibiotic Roseofungin produced by actinomycetes possessing wide range of antimicrobial activity. <b>Methods:</b> The structure of novel polyene antibiotic Roseofungin was confirmed through FTIR, H<sup>1</sup> nuclear magnetic resonance, and high-performance liquid chromatography analysis with a mass detector. The substance pharmaco-technological parameters were evaluated. Additionally, the in silico modelling of various physicochemical parameters and biological activities was performed using validated open-access software tools such as ProTox3, SwissADME, and ADMET SAR1. The evaluation of its toxicological profile was also investigated in vivo. <b>Results:</b> The Roseofungin exhibits potential risks in certain categories, including immunotoxicity, respiratory toxicity, and nephrotoxicity, as predicted in silico. However, Roseofungin shows a relatively safe profile with regard to hepatotoxicity, neurotoxicity, and mutagenicity, along with lower risks of carcinogenicity and cytotoxicity in silico. The analysis of body weight dynamics after Roseofungin exposure in mice revealed no statistically significant differences among the experimental groups. Similarly, in the absolute or relative weights of internal organs across the experimental groups after Roseofungin treatment, no significant differences were observed in vivo. Roseofungin appears as a light-yellow hygroscopic powder with a specific odour, possessing the ability to settle and classified as a light powder. The particles are lamellar crystals ranging in size from 3 μm to 6 μm, and the molecules generate electrostatic tension between themselves. The pharmaco-technological parameters of Roseofungin were comprehensively studied. <b>Conclusions:</b> The experimental data obtained provide a foundation for further pharmaceutical development of new drugs containing the original Roseofungin.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-03-27
DOI
https://doi.org/10.3390/pharmaceutics17040430
Citations
1
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development

Gul Baimakhanova, С.Э. ОРАЗЫМБЕТ, А.К. САДАНОВ, Diana Tleubekova et al.
1 citations
Pharmaceutics
Microbial Natural Products and Biosynthesis
1.39
article

Pharmaco-Technological Characterization, Structural Analysis, and Toxicological Evaluation of the Novel Polyene Antibiotic Roseofungin for Drug Development

Gul Baimakhanova, С.Э. ОРАЗЫМБЕТ, А.К. САДАНОВ, Diana Tleubekova, Gulbanu Sarsenbayeva, Liliya Ibragimova, Dmitriy Berillo, B.B. BAIMAKHANOVA, Gulnar T. Dzhakibaeva, Olga Lakh, Tulegen Mussaldinov, Assya Bagimbayeva, Iliyas Raikhanovich Kulmaganbetov, Farida Nurmaganbetova
article en
1 citations

Abstract

<b>Background/Objectives:</b> pentane polyene antibiotic Roseofungin produced by actinomycetes possessing wide range of antimicrobial activity. <b>Methods:</b> The structure of novel polyene antibiotic Roseofungin was confirmed through FTIR, H<sup>1</sup> nuclear magnetic resonance, and high-performance liquid chromatography analysis with a mass detector. The substance pharmaco-technological parameters were evaluated. Additionally, the in silico modelling of various physicochemical parameters and biological activities was performed using validated open-access software tools such as ProTox3, SwissADME, and ADMET SAR1. The evaluation of its toxicological profile was also investigated in vivo. <b>Results:</b> The Roseofungin exhibits potential risks in certain categories, including immunotoxicity, respiratory toxicity, and nephrotoxicity, as predicted in silico. However, Roseofungin shows a relatively safe profile with regard to hepatotoxicity, neurotoxicity, and mutagenicity, along with lower risks of carcinogenicity and cytotoxicity in silico. The analysis of body weight dynamics after Roseofungin exposure in mice revealed no statistically significant differences among the experimental groups. Similarly, in the absolute or relative weights of internal organs across the experimental groups after Roseofungin treatment, no significant differences were observed in vivo. Roseofungin appears as a light-yellow hygroscopic powder with a specific odour, possessing the ability to settle and classified as a light powder. The particles are lamellar crystals ranging in size from 3 μm to 6 μm, and the molecules generate electrostatic tension between themselves. The pharmaco-technological parameters of Roseofungin were comprehensively studied. <b>Conclusions:</b> The experimental data obtained provide a foundation for further pharmaceutical development of new drugs containing the original Roseofungin.

PharmaceuticsVol. 17(4)
Kazakh National Medical University (KZ), Manash Kozybayev North Kazakhstan University (KZ)
Ministry of Education and Science of the Republic of Kazakhstan
Good health and well-being
Openalex Percentile: Top 22%
Microbial Natural Products and Biosynthesis
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.